Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SKB reports new delta-receptor agonists/antagonists

Jan. 16, 1997

New antimigraine agent from Pfizer

Jan. 15, 1997

Japanese scientists report cholecystokinin antagonists

Jan. 15, 1997

Second IND submitted for new ADHD therapy

Jan. 14, 1997

Subcutaneous BDNF not effective in ALS

Jan. 14, 1997

Neurogen reports CRF ligands for stress-related disorders

Jan. 14, 1997

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Jan. 13, 1997

MRC scientists investigate role of somatostatin receptors in the CNS

Jan. 13, 1997

French researcher discloses preventive effects of tryptamine derivatives

Jan. 13, 1997

Titan in-licenses antipsychotic drug from HMR

Jan. 10, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...